Member Log-in

I forgot my password

Not a Member? Register

Updates

Find the latest news and peer-reviewed publications related to Gavi transition and immunization, as well as upcoming events of interest to LNCT members.

  • LNCT Updates
  • Global Updates

Blog

Hesitancy on the Frontline: Lessons Learned in Preparing for and Responding to Health Care Worker Hesitancy

Authors: Regina Madanguit, Felicity Pocklington, Michael Coleman, Sherine Guirguis, and Amel Benzerga To help you address specific vaccine hesitancy and demand issues in your country, you can sign up for a one-on-one meeting with Common Thread. Whether it’s a strategy, a crisis communication plan, or something you can’t quite define, our public health experts, communicators, … Continued

Combating Vaccine Hesitancy through Storytelling: Four Key Insights on the Power of this Persuasive Approach

Authors: Leah Ewald and Felicity Pocklington Seated on the front porch of her house, perched on the side of a mountain in the vibrant green landscape of Yen Bai Province, Vietnam, with the steady sounds of daily life humming in the background, a woman named Cha tells us who she is in her own words. … Continued

How to End a Pandemic: 5 Ways to Overcome Covid Vaccine Hesitancy

This blog was written by Sherine Guirguis, Co-Director of Common Thread, and originally appeared on Common Thread’s Medium blog. Vaccination — a photo by CDC on Unsplash By Sherine Guirguis, Co-Director of Common Thread Common Thread puts people at the centre of Public Health. Find us at: gocommonthread.com “I’m pretty sure I had Covid last October. I never get … Continued

News

Want to Talk to Experts About Your Vaccine Hesitancy and Demand Issues? Sign Up Now for Upcoming Office Hours with Behavioral Design Experts from Common Thread!

Is your country experiencing urgent vaccine hesitancy or demand issues as a result of COVID-19? LNCT is pleased to offer you an opportunity to talk with behavioral scientists, public health experts, communicators, and designers from Common Thread about these issues during an upcoming “office hour” session in August. How to sign up: LNCT countries can sign up for a one-hour “office hour” … Continued

Third Module of LNCT’s New Free Online Course on Vaccine Hesitancy and Demand Generation Now Available!

Dear LNCT members, We are pleased to announce that the third module of LNCT’s  online course on vaccine hesitancy and demand generation, “Building knowledge and awareness about immunization amongst caregivers and families”  is now available to the public in English, French, Portuguese and Russian. Developed in partnership with Common Thread, this module focuses on why building knowledge and … Continued

Second Module of LNCT’s New Free Online Course on Vaccine Hesitancy and Demand Generation Now Available to the Public

Dear LNCT members, We are pleased to announce that the second module of LNCT’s new online course on vaccine hesitancy and demand generation, “Using data to understand immunization behavior and build demand strategies” is now available to the public in English, French, Portuguese and Russian. Developed in partnership with Common Thread, this module outlines the importance of using data to design … Continued

News

What is Driving COVID-19 Vaccine Hesitancy in Sub-Saharan Africa?

Angola, Cote d’Ivoire, Ghana, Nigeria

This article originally appeared on the World Bank Blog. Below is an excerpt.  A 2020 Africa Centre for Disease Control (Africa CDC) survey in 15 countries found that while 79% of respondents would take a COVID-19 vaccine, vaccine hesitancy ranged from four to 38% (see figure 1 for more estimates). In a recent five-country Afrobarometer survey  six out of … Continued

Vaccine Acceptance is the Next Hurdle

This story originally appeared on the World Health Organization’s website.  COVID-19 vaccines are finally within reach, with several breakthroughs on the horizon. This is good news at the end of a difficult pandemic year. But even after we have overcome the imminent challenges of sufficient supply, efficient rollout and equitable access, vaccine hesitancy will remain … Continued

Choose a Language